MYEOV

Across TCGA pan-cancer cohorts, MYEOV RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated MYEOV data layer compared with 3 for mutation status.

The strongest signal is observed in uveal melanoma (UVM), where higher MYEOV RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MYEOV expression acts as an unfavorable survival marker, although some lineages such as UCS and READ show a favorable association.

UVM, ACC, and PAAD are the cancer types where MYEOV RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Median	All	0.404	0.835	<.001	142	view →
ACC	OS	Median	All	0.446	0.779	<.001	100	view →
PAAD	OS	Median	All	0.237	0.534	<.001	95	view →
LUAD	DFS	Median	All	0.738	0.839	.001	50	view →
LUSC	OS	Tertile	All	0.563	0.719	.002	40	view →
MESO	OS	Median	All	0.277	0.495	<.001	38	view →
UCS	DFS	Tertile	IV	0.906	0.275	.024	24	view →
LIHC	OS	Tertile	All	0.444	0.677	.009	22	view →
KIRP	DFS	Tertile	IV	0.045	0.765	.010	22	view →
READ	DFS	Median	II,III,IV	0.653	0.234	.016	19	view →
HNSC	OS	Median	All	0.316	0.481	.007	14	view →
BRCA	DFS	Median	IV	0.315	0.712	.002	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

MYEOV–UVM (OS)

Open the UVM breakdown →